179 related articles for article (PubMed ID: 38211557)
1. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
3. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
[TBL] [Abstract][Full Text] [Related]
4. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
Fan C; Gao Y; Sun Y
Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
[TBL] [Abstract][Full Text] [Related]
6. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
7. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
[TBL] [Abstract][Full Text] [Related]
9. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
11. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses.
Yuan S; Xu F; Li X; Chen J; Zheng J; Mantzoros CS; Larsson SC
Cell Rep Med; 2023 Sep; 4(9):101174. PubMed ID: 37652020
[TBL] [Abstract][Full Text] [Related]
12. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
13. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
Chen L; Zhao Y; Li M; Lv G
Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis.
Jin H; Kim YA; Lee Y; Kwon SH; Do AR; Seo S; Won S; Seo JH
BMC Med; 2023 Jan; 21(1):16. PubMed ID: 36627639
[TBL] [Abstract][Full Text] [Related]
15. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
Zhou S; Tian Y; Song X; Xiong J; Cheng G
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
[TBL] [Abstract][Full Text] [Related]
16. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
Yang H; Chen L; Liu Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
[TBL] [Abstract][Full Text] [Related]
17. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
18.
Li Y; Jin L; Yan J; Zhang H; Zhang R; Hu C
Mediators Inflamm; 2021; 2021():5521050. PubMed ID: 33958973
[TBL] [Abstract][Full Text] [Related]
19. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.
Wang Q; Shi Q; Wang Z; Lu J; Hou J
BMC Med; 2023 Sep; 21(1):377. PubMed ID: 37775746
[TBL] [Abstract][Full Text] [Related]
20. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
